The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global histology and cytology market reached a value of US$ 13.22 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 25.72 Billion by 2027, exhibiting a CAGR of 11.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Histology and cytology are branches of biology dealing with chemistry, structure and function of tissues and cells of animals and plants at a microscopic level. They assist medical staff in diagnosing diseases, such as cancer, cervical disease, tuberculosis, human papilloma virus (HPV) infection, abnormal growth, inflammatory diseases, leukemia, smallpox, and rabies. They also help enhance the sensitivity, specificity and accuracy of diagnostic methods. As a result, they find extensive applications in hospitals, clinics, and research and development (R&D) institutes across the globe.
At present, there is a rise in the number of cancer patients across the globe. This, along with the favorable reimbursement policies for laboratory tests, represents one of the key factors driving the market. Moreover, the growing integration of digital solutions in cytological diagnosis aids in rapidly interpreting primary diagnostic data, which is positively influencing the market. In addition, major manufacturers are launching new and advanced cytology systems for helping in the rapid on-site evaluation of cytology samples. This, coupled with the rising traction of immunohistochemistry (IHC) for visualizing cellular components, is propelling the growth of the market. Besides this, there is an increase in the standardization of pathological laboratories around the world. This, along with technological advancements in diagnostic and molecular techniques, is contributing to the growth of the market. Additionally, increasing awareness about the advanced therapeutics and enhanced healthcare infrastructure worldwide is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on acquisitions, mergers, partnerships, and collaborations to expand their customer base. They are also launching new products and receiving product approvals from regulatory authorities, which is projected to bolster the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global histology and cytology market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, type of examination, test type and application.
Breakup by Product:
Breakup by Type of Examination:
Breakup by Test Type:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc. and Trivitron Healthcare.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Type of Examination, Test Type, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc. and Trivitron Healthcare.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global histology and cytology market was valued at US$ 13.22 Billion in 2021.
We expect the global histology and cytology market to exhibit a CAGR of 11.20% during 2022-2027.
The rising usage of histology and cytology in diagnosing numerous diseases, such as cancer, cervical disease, tuberculosis, etc., as well as in enhancing the sensitivity, specificity, and accuracy of diagnostic methods, is primarily driving the global histology and cytology market.
The sudden outbreak of the COVID-19 pandemic has led to the rising adoption of histology and cytology methods to understand the nature of the coronavirus infection and develop novel vaccines to combat the risk of disease spread.
Based on the product, the global histology and cytology market can be segmented into instruments and analysis software system and consumable and reagents. Currently, consumable and reagents hold the majority of the total market share.
Based on the type of examination, the global histology and cytology market has been divided into histology and cytology, where cytology exhibits a clear dominance in the market.
Based on the test type, the global histology and cytology market can be categorized into microscopy tests, molecular genetics tests, and flow cytometry. Among these, microscopy tests account for the majority of the global market share.
Based on the application, the global histology and cytology market has been segregated into drug discovery and designing, clinical diagnostics, and research. Currently drug discovery and designing holds the largest market share.
On a regional level, the market can be classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global histology and cytology market include Abbott Laboratories, Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., and Trivitron Healthcare.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at